Valar Labs, a Palo Alto, CA-based company that aims to innovate the cancer treatment decision process with Artificial Intelligence, raised $4M in seed funding.
The round was led by Andreessen Horowitz with participation from Dave King (former CEO Labcorp), Peer Schatz (former CEO Qiagen), Devin Carty (Martin Ventures, former CSO at Cancer Treatment Centers of America), Arif Nathoo & Web Sun (Founders of Komodo Health), Johannes Schildt (CEO Kry), Andy Palmer (Koa Labs), Steve Blank (Stanford Lean Launchpad), Charles Roberts (CGO Freenome), Ahsan Amjad (CEO ABC Labs), Maria Rankka (Co-founder ABC Labs), Per Båtelson (Founder Takura), Saharsh Patel (COO Canva Health), Monishika Gupta (WellBeam), Nikita Andersson (Hummingbird VC), Cavin Mozarmi (Remus Capital) among others.
The company intends to use the funds to continue to expand operations and its development efforts.
Led by Damir Vrabac (COO), Anirudh Joshi (CEO) & Viswesh Krishna (CTO), Valar Labs provides an AI powered computer vision and digital patology tool to improve cancer care management and related decisions. The company is building clinical grade deep learning to analyze each patient’s characteristics and provide clarity to oncologists during decision making. The AI is built with oncologists at the center and provides interpretable and actionable insights.